ASH 2022: Brukinsa Bests Imbruvica In Leukemia/Lymphoma PFS

Adds To ORR Benefits Shown Earlier

 
• By Dexter Jie Yan
  
Brukinsa final win
BeiGene finally hits finish line of comparative ALPINE trial in triumph • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from China

More from Focus On Asia